Ascendis Pharma A/S (ASND) vs Madrigal Pharmaceuticals, Inc. (MDGL)

Ascendis Pharma A/S and Madrigal Pharmaceuticals, Inc. are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $15.7B against $11.9B — 1.3× the size. Madrigal Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 16.3×. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 149.0% against 126.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs −25.3%) and the higher return on invested capital (15.1% vs −787.3%). Across the 17 metrics below, Ascendis Pharma A/S leads on 11 and Madrigal Pharmaceuticals, Inc. on 6.